Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group.

ABSTRACT:

SUBMITTER: Damaschin C 

PROVIDER: S-EPMC8807388 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature